Fast-dissolving drug-delivery systems (FDDS) serve a major benefit over the conventional dosage forms because the drug gets disintegrated rapidly and dissolves in the saliva without the use of water. Lisinopril is the lysine analog of enalapril which was used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals after myocardial infarction and to prevent the progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy. The drug is found to be absorbed slowly and incompletely from the gastrointestinal tract (oral) bioavailability of the drug is ∼25% in order to increase bio availability lisinopril was formulated as fast dissolving sublingual film A total of 10 formulations of Fast dissolving sublingual film of lisinopril was prepared by using different polymers like HPMC E15, HPMCE5, HPMC E3, HPMC K 15, PVP, PEG 400 as plasticizer, SSG as a super disintegrant. Among them F10 formulation containing HPMC E 3 and PVP in combination of 4:1 ratio with SSG as a super disintegrant showed 95.69 % drug released in 10 minutes and which was disintegrated in 95 sec .
INTRODUCTION

Fast dissolving sublingual films
The concept of sublingual films has been introduced to overcome the problems associated with conventional oral dosage forms and improve bioavailability there by optimization of therapy.
Fast dissolving films are most advance form of solid dosage form due to flexibility. It improve efficacy of active pharmaceutical ingredient [API] dissolving in short duration oral cavity after the contact with less amount of saliva as compared to dissolving tablet.¹ Ideal characteristics for a drug to formulate it into sublingual film²:

The drug should have pleasant taste.
The drug that is incorporated should have low dose up to 40mg.
The drug with smaller and moderate molecular weight is preferable.
The drug should have good stability and solubility in water as well as in saliva  It should be have partially unionized at the pH of oral cavity.
It should have the ability to permeate oral mucosal tissues.
Advantages of sublingual film 3, 4, 5 :
 fast delivery of Lisinopril with better bioavailability and enhanced patient compliance.
MATERIALS
All the materials used in this study (Lisinopril, HPMC E15,  HPMCE5, HPMC E3, HPMC K 15, PVP, SLS, SSG, PEG 400 , Sucralose, Peppermint oil, Citric acid) were obtained from Sree srinivasa scientifics, Hyderabad
METHODOLOGY
Preparation of fast dissolving sublingual films 6-10 :
Fast dissolving sublingual film was prepared by solvent casting method. A total of 10 formulations were prepared by using different polymers, super disintegrating agent, plasticizer in combination. Total water was divided into two parts in one part drug is dissolved and in other part polymer, plasticizer, super disintegrant and flavouring agents were dissolved. Part one is added to the part two with stirring and sonicated for 10 mins to remove the entrapped air, the solution was poured into petridish and an inverted funnel was placed over it. Kept for evapouration for 24 hours. The formed patch was removed and analyzed. 
Method:
The pure drug of about 10 mg was weighed and transferred in to a 10ml volumetric flask. The drug was dissolved completely in a few ml of 0.1N NaOH and made up to the final volume with NaOH to get a stock solution of concentration 1000μg/ml. Aliquots of standard stock solution were pipette out and diluted suitably with water to get the final concentration of standard solutions.
Absorption maxima method:
The solutions were scanned in the range of 400-200 nm against 0.1N NaOH as reference, and the peaks were observed in the spectra at 218nm. The wavelength selected for analysis of drug was 218nm. The drug obeys the lamberts law in the range of 2-12 μg/ml. By using linearity plot the quantification was carried out.
Compatibility studies by FTIR
The drug and excipient compatibility studies were carried out by FTIR study.
Thickness:
The thickness of the patch was measured using digital VernierCalliper with a least count of 0.01 mm at different spots of the film. The thickness was measured at three different spots of the patch and average was taken and SD was calculated.
Weight variation:
Four centimeter square of the film was cut at three different places from the casted film. The weight of each film was taken and weight variation was calculated
Folding endurance:
Folding endurance was determined by repeated folding of the film at the same place till the strip breaks. The number of times the film is folded without breaking was computed as the folding endurance value.
Tensile strength:
Tensile strength is the maximum stress applied to a point at which the film specimen breaks. It is calculated by the applied load at rupture divided by the cross-sectional area of the film as given below:
Tensile strength = Load at failure ×100/ Film thickness × film width
Percent elongation:
Film sample stretches when stress is applied and it is referred to as strain.Strainis basically the deformation of film divided by original dimension of the sample. Elongation of film increases as the plasticizer content increases.
Percent Elongation= L * 100/ Lo
Where, L = Increase in length of film, Lo = Initial length of film. The film to be tested was placed in a petri dish and was moistened with0.5ml of distilled water and kept for 30sec.The pH was noted after bringing the electrode of the pH meter in contact with the surface of the formulation and allowing equlibriation for 1min. The average of three determinations for each formulationwas done.
Uniformity of drug content
This parameter was determined by dissolving one film of dimension 2 x 2 cm by homogenization in 100 ml of stimulated saliva of pH 6.8 for 30 min with continuous shaking. . From this, 10 ml was diluted to 50 ml with simulated salivary fluid. The absorbance was measured using an UV spectrophotometer. The experiments were carried out in triplicate for the films of all formulations and average values were recorded.
In Vitro permeation studies through egg membrane:
Permeation studies were carried using the modified Franz diffusion cell of internal diameter of 2.5 cm. The egg membrane was separated by using concn HCL then washed in isotonic phosphate buffer of pH 6.8 and used immediately. The egg membrane was mounted between the donor and receptor compartments. The receptor compartment was filled with 25 mL of isotonic phosphate buffer of pH 6.8. Which was maintained at 37 ± 0.2ºC and the hydrodynamics were maintained by stirring with a magnetic bead at 50 rpm. One film of dimensions 2 x 2 cm, previously weighed, was placed in intimate contact with the mucosal surface of the membrane that was previously moistened with a few drops of simulated saliva. The donor compartment was filled with 1 mL of simulated saliva of pH 6.8. Samples 
RESULTS AND DISCUSSION
Compatibility studies by FTIR:
The study showed peaks for the corresponding functional groups in Lisinopril. When the study was carried out with the combination of Lisnopril and polymers, there were no major changes in the peaks. Hence there was no interaction with the polymers. The results were shown below transparency. Plasticization with Propylene glycol provided higher strength and better elongation characters to the films. The reason attributed to this is as the major parts of the films were HPMC which is hydrophilic polymer, the hydrophilic plasticizer Propylene glycol could reduce the glass transition temperature of the film. After getting a desired flexible film different concentration of super disintegrants was employed in order to achieve fast dissolution. Physical appearance: All the sublingual films were visually inspected for colour, clarity, flexibility.
a. Weight of the film
Drug loaded films (2x2 cm2) were tested for uniformity of weight. The films were found uniform. The average weight of the film was found to be in the range of 51 ± 1.00 to 56 ± 1.20mg. as the polymer content increase, the weight of the patch also increased.
b. Thickness of the film
All the films have uniform thickness throughout. Average thickness was found to be in the range of 0.10 ± 0.005 to 0.16 ± 0.010 mm. As the polymeric content increases, the thickness of the patch also increases.
c. Moisture content
Moisture content in F1 to F10 were found to be in the range of 3 to 7%.
d. Drug content determination
It was determined for all formulation by UV spectrophotometer method shown in table. The data obtained from triplicate studies were analyzed for mean and standard deviation. The results of content uniformity indicated that the drug was uniformly dispersed. Recovery was possible to the tune of 85.67 to 95.69 %.
e. Tensile strength
Ideal sublingual film should be flexible, elastic and strong enough to withstand breakage due to stress caused during its residence in the mouth. The tensile strength shows the strength and elasticity of the film. A soft and weak polymer is characterized by low TS; a hard and brittle polymer is defined by a moderate TS, a soft and tough polymer is characterized by a moderate TS, whereas a hard and tough polymer is characterized by high TS. Tensile Strength increased with the increase in polymeric content. Maximum TS was exhibited by F6 batch (8.6 ± 0.04 kg/cm2) and minimum was exhibited by F5 batch (3.6 ± 0.13 kg/cm2).
f. Folding endurance
Folding endurance measures the ability of film to withstand rupture. Patch did not show any cracks even after folding for more than 300 times. Hence it was taken as the end point. Folding endurance did not vary when the comparison was made between plain patch and drug loaded patch.
In-vitro diffusion studies:
The percentage amount of drug diffusion is plotted against time to obtain the diffusion profile. It was found that in 10 min, the entire quantity of the released drug from the formulation diffused completely and hence indicated a good diffusion coefficient, which is essential for faster onset of action. Formulation F4 showed minimum drug release (41.71 %) and F10 Formulation showed a maximum drug release of (95.69%). Stability studies were carried out for 45 days at 2-8°C (45% RH) and 25-30°C (60% RH). The films were observed for physical changes, the percentage drug content and the percentage drug release. Fast-dissolving films of lisinopril were found to be physically and chemically stable and showed no significant change in terms of physical characteristics, the percentage drug content and the percentage drug release. 
CONCLUSION
Fast-dissolving drug-delivery systems (FDDS) serve a major benefit over the conventional dosage forms because the drug gets disintegrated rapidly and dissolves in the saliva without the use of water. Lisinopril is the lysine analog of enalapril which was used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals after myocardial infarction and to prevent the progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy. The drug is found to be absorbed slowly and incompletely from the gastrointestinal tract (oral) Bioavailability of the drug is ∼25% inorder to increase bio availability lisinopril was formulated as fast dissolving sublingual film .A total of 10 formulations of Fast dissolving sublingual film of lisinopril was prepared by using different polymers like HPMC E15, HPMCE5, HPMC E3, HPMC K 15, PVP, plasticizer PEG 400, SSG as a super disintegrant .Among them F10 formulation containg HPMC E 3 and PVP in combination of 4:1 ratio with SSG as a super disintegrant showed 95.69 % drug released in 10 mins and which was disintegrated in 95 sec. The optimized formulation was kept for stability studies no significant changes were observed after 3 month in the disintegration time and drug content.
